Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma modelY. Kususda(Kobe University), M. Fujisawa(Kobe University)British Journal of CancerMay 15, 201210.1038/bjc.2012.209Cited by 42SaveCiteExport RISWatch citationsRelated PapersAcquired resistance to temsirolimus in human renal cell carcinoma cells is mediated by the constitutive activation of signal transduction pathways through mTORC2|British Journal of Cancer|2013|39Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells|British Journal of Cancer|2009|16